COLGATE TOTAL Drug Patent Profile

Which patents cover Colgate Total, and when can generic versions of Colgate Total launch?

Colgate Total is a drug marketed by Colgate Palmolive and is included in one NDA.

The generic ingredient in COLGATE TOTAL is sodium fluoride; triclosan. There are one thousand four hundred and seventy-two drug master file entries for this compound. Additional details are available on the sodium fluoride; triclosan profile page.

Summary for COLGATE TOTAL

US Patents:	0
Applicants:	1
NDAs:	1
Raw Ingredient (Bulk) Api Vendors:	4
Clinical Trials:	31
Patent Applications:	413
DailyMed Link:	COLGATE TOTAL at DailyMed

Recent Clinical Trials for COLGATE TOTAL

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
Universidade Federal do Para	Phase 3
University of Baghdad	Phase 3
University of California, San Francisco	Early Phase 1

See all COLGATE TOTAL clinical trials

US Patents and Regulatory Information for COLGATE TOTAL

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Colgate Palmolive	COLGATE TOTAL	sodium fluoride; triclosan	PASTE;DENTAL	020231-001	Jul 11, 1997		DISCN	Yes	No

Expired US Patents for COLGATE TOTAL

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Colgate Palmolive	COLGATE TOTAL	sodium fluoride; triclosan	PASTE;DENTAL	020231-001	Jul 11, 1997
Colgate Palmolive	COLGATE TOTAL	sodium fluoride; triclosan	PASTE;DENTAL	020231-001	Jul 11, 1997
Colgate Palmolive	COLGATE TOTAL	sodium fluoride; triclosan	PASTE;DENTAL	020231-001	Jul 11, 1997
Colgate Palmolive	COLGATE TOTAL	sodium fluoride; triclosan	PASTE;DENTAL	020231-001	Jul 11, 1997
Colgate Palmolive	COLGATE TOTAL	sodium fluoride; triclosan	PASTE;DENTAL	020231-001	Jul 11, 1997

International Patents for COLGATE TOTAL

See the table below for patents covering COLGATE TOTAL around the world.

Country	Patent Number	Title	Estimated Expiration
Hungary	T59302
Zambia	5289	PACKAGED ANTI-PLAQUE ORAL COMPOSITIONS
Portugal	86661	PROCESSO PARA A PREPARACAO DE UMA COMPOSICAO ORAL ANTI-BACTERIANA ANTI-PLACA, ANTI-CALCULO, CONTENDO UM AGENTE ANTI-CALCULO DE POLIFOSFATO
Czech Republic	281211	Polymer a způsob přípravy tohoto polymeru (POLYMER AND PROCESS FOR PREPARING SAID POLYMER)
Mexico	9303474	COMPOSICION DE ENJUAGUE BUCAL ANTIPLACA ANTIBACTERIAL.

Supplementary Protection Certificates for COLGATE TOTAL

Patent Number	Supplementary Protection Certificate	SPC Country	SPC Expiration	SPC Description
2203431	CA 2015 00014	Denmark		PRODUCT NAME: DASABUVIR OR A SALT THEREOF, INCLUDING DASABUVIR SODIUM MONOHYDRATE; REG. NO/DATE: EU/1/14/983 20150115
2465580	SPC/GB21/030	United Kingdom		PRODUCT NAME: CABOTEGRAVIR OR A PHARMACEUTICALLY ACCEPTABLE SALT OR SOLVATE THEREOF, INCLUDING CABOTEGRAVIR SODIUM.; REGISTERED: UK EU/1/20/1481 (NI) 20201221; UK PLGB 35728/0055-57 20201221
0579826	SPC/GB02/042	United Kingdom		PRODUCT NAME: ERTAPENEM ((1R,5S,6S,8R,2'S,4'S)-2-(2-(3-CARBOXYPHENYLCARBAMOYL)PYRROLIDIN-4-YLTHIO)-6-(1-HYDROXYETHYL)-1-METHYLCARBAPENEM-3-CARBOXYLIC ACID), A PHARMACEUTICALLY ACCEPTABLE SALT OR IN VIVO HYDROLYSABLE ESTER THEREOF, ESPECIALLY AS THE MONOSODIUM SALT ERTA; REGISTERED: UK EU/1/02/216/001 20020422
0145340	99C0005	Belgium		PRODUCT NAME: FOSPHENYTOIN DISODIUM; NAT. REGISTRATION NO/DATE: NL 23 613 19980806; FIRST REGISTRATION: GB - PL 000 19/0157 19980204
2203431	92666	Luxembourg		PRODUCT NAME: DASABUVIR OU UN SEL QUI EN DERIVE, Y COMPRIS DASABUVIR SODIUMMONOHYDRATE. FIRST REGISTRATION: 20150119

COLGATE TOTAL Market Analysis and Financial Projection Experimental

Market Dynamics and Financial Trajectory of Colgate-Palmolive

Introduction

Colgate-Palmolive, a global leader in the consumer goods sector, has consistently demonstrated strong market performance and financial resilience. Here, we delve into the company's recent market dynamics and financial trajectory, highlighting key metrics, strategies, and future outlook.

Market Leadership

Colgate-Palmolive maintains a dominant position in the oral care market. As of the third quarter of 2024, the company held a global market share of 41.6% in toothpaste and 32.3% in manual toothbrushes[1][2][3].

Sales Performance

In the third quarter of 2024, Colgate-Palmolive reported a 2.4% increase in net sales, with organic sales growing by 6.8%. This growth was driven by a combination of volume increases and higher pricing across all operating divisions[1].

For the second quarter of 2024, the company saw net sales rise by 4.9%, with organic sales growth of 9.0%. This robust performance was consistent across developed and emerging markets, with developed markets growing by 3% and emerging markets by 4.6% in the third quarter[2][3].

Gross Profit Margin

Colgate-Palmolive has shown significant improvement in its gross profit margins. In the third quarter of 2024, the GAAP gross profit margin increased by 260 basis points to 61.1%, while the Base Business gross profit margin rose by 270 basis points to 61.3%[1]. Similarly, in the second quarter, the gross profit margin expanded by 280 basis points to 60.6%, and the Base Business gross profit margin increased by 300 basis points to 60.8%[2].

Earnings Per Share (EPS)

The company's earnings per share have also seen substantial growth. In the third quarter of 2024, GAAP EPS increased by 5% to $0.90, while Base Business EPS rose by 6% to $0.91. For the second quarter, GAAP EPS increased by 48% to $0.89, and Base Business EPS grew by 18% to $0.91[1][2].

Cash Flow and Financial Health

Colgate-Palmolive has maintained strong cash flow. For the first nine months of 2024, net cash provided by operations was $2,838 million. This robust cash flow enables the company to invest in long-term growth initiatives and maintain its financial health[1].

Advertising and Brand Investment

The company has increased its advertising investment, which rose by 18% in the second quarter of 2024. This strategic focus on brand health and market penetration has been crucial in driving sales growth and maintaining market leadership[2].

Full-Year Guidance

Colgate-Palmolive has updated its full-year 2024 guidance, reflecting its confidence in the current market dynamics. The company expects net sales growth of 2% to 5%, including a mid-single-digit negative impact from foreign exchange. Organic sales growth is expected to be in the range of 6% to 8%, up from the previous range of 5% to 7%. Base Business EPS growth guidance has also been increased to 8% to 11%[2].

Market Challenges and Strategies

Despite facing challenges such as pricing pressures in North America and political volatility in emerging markets, Colgate-Palmolive has managed to deliver strong results. The company's focus on innovation, productivity, and efficiency has been key in navigating these challenges. CEO Noel Wallace expressed confidence in the company's growth strategy and innovation pipeline heading into 2025[3].

Historical Performance

Looking back, Colgate-Palmolive's full-year 2023 results were equally impressive, with net sales and organic sales both increasing by 8.5%. This marked the company's fifth consecutive year of organic sales growth within its targeted range of 3% to 5%[4].

Financial Statements and Projections

As of the latest financial statements, Colgate-Palmolive's total revenue stood at $19.5 billion, with a cost of revenue of $8.2 billion. The company's research and development to revenue ratio remains stable at 0.02, indicating a continued commitment to innovation[5].

Investor Insights

For investors, Colgate-Palmolive's financial health is a significant factor. The company's ability to maintain high gross profit margins and generate strong cash flow positions it well for future growth. Here is a highlight from an industry expert:

"Colgate-Palmolive operates with impressive gross profit margins, which is crucial for maintaining profitability and funding innovation initiatives."[3]

Conclusion

Colgate-Palmolive's market dynamics and financial trajectory are characterized by strong sales growth, improved gross profit margins, and robust cash flow. The company's strategic focus on innovation, brand health, and market penetration has enabled it to navigate challenging market conditions effectively.

Key Takeaways

• Market Leadership: Colgate-Palmolive maintains a dominant position in toothpaste and manual toothbrushes globally.
• Sales Growth: The company has reported significant increases in net and organic sales across all divisions.
• Gross Profit Margin: Gross profit margins have expanded substantially, contributing to improved profitability.
• EPS Growth: Earnings per share have seen notable increases, reflecting strong bottom-line performance.
• Cash Flow: Robust cash flow supports long-term growth initiatives and financial health.
• Full-Year Guidance: Updated guidance reflects confidence in achieving higher organic sales and EPS growth.

FAQs

Q: What is Colgate-Palmolive's global market share in toothpaste and manual toothbrushes? A: As of the third quarter of 2024, Colgate-Palmolive holds a global market share of 41.6% in toothpaste and 32.3% in manual toothbrushes[1].

Q: How has Colgate-Palmolive's net sales and organic sales performed in recent quarters? A: In the third quarter of 2024, net sales increased by 2.4%, and organic sales grew by 6.8%. In the second quarter, net sales rose by 4.9%, and organic sales grew by 9.0%[1][2].

Q: What are the key drivers of Colgate-Palmolive's gross profit margin expansion? A: The expansion is driven by a combination of volume growth, higher pricing, and improved operational efficiency across all divisions[1][2].

Q: How has Colgate-Palmolive's earnings per share (EPS) performed recently? A: In the third quarter of 2024, GAAP EPS increased by 5%, and Base Business EPS rose by 6%. For the second quarter, GAAP EPS increased by 48%, and Base Business EPS grew by 18%[1][2].

Q: What is Colgate-Palmolive's updated full-year 2024 guidance? A: The company expects net sales growth of 2% to 5%, organic sales growth of 6% to 8%, and Base Business EPS growth of 8% to 11%[2].

Sources

1. Colgate Announces 3rd Quarter 2024 Results - Colgate-Palmolive Investor Relations
2. Colgate Announces 2nd Quarter 2024 Results - Stock Titan
3. Earnings call: Colgate-Palmolive reports robust Q3 growth amid challenges - Investing.com
4. Colgate Announces 4th Quarter and Full Year 2023 Results - Colgate-Palmolive Investor Relations
5. Colgate Financial Statements From 2010 to 2024 - Macroaxis